文献速递肿瘤 PET/CT骨显像与常规 SPECT

全身[18F]-FDG-PET/MRI用于儿童非霍奇金淋巴瘤分期:单中心首次评估结果

Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation.
PubMed 文献 · EJNMMI Res · 2021-07-03

结果显示PET与MRI联合可综合代谢、功能与形态信息解决分歧,在部分临床评估阴性的患者中检出Waldeyer环受累,并检出胸膜腔积液及骨骼病灶;作者认为尽管例数少,全身[18F]-FDG-PET对儿童非霍奇金淋巴瘤分期有价值。

要点

  • PET与MRI分别判读后共识复核,综合代谢、功能与形态信息解决分歧。
  • PET/MRI在临床评估阴性的2例中检出Waldeyer环受累,并检出骨骼病灶。

核心结论

  • 尽管评估病例数少,全身[18F]-FDG-PET在儿童非霍奇金淋巴瘤分期中是有价值的工具。

研究设计与样本

  • 分析分三步:核医学医师与儿科放射科医师分别判读[18F]-FDG-PET与MR;对差异发现共同复核达成共识;将[18F]-FDG-PET/MRI发现与其他临床检查结果关联。
  • 判读范围包括19个淋巴结区域、2个结外区域及6个器官。

主要发现

  • 在评估的190个淋巴结区域中,4个被评为有争议,通过综合代谢、功能与形态信息达成共识。
  • [18F]-FDG-PET与MRI一致在2例临床评估Waldeyer环阴性的患者中检出Waldeyer环受累。
  • 4例患者MRI显示胸膜腔积液,但仅其中2例可检出葡萄糖代谢增高作为胸膜受累的可靠征象。
  • 6例患者[18F]-FDG-PET与MRI检出骨骼病灶,而骨髓活检仅1例阳性。

临床怎么用

  • 儿童非霍奇金淋巴瘤分期可考虑全身[18F]-FDG-PET/MRI,综合代谢、功能与形态信息判读。
  • 对MRI显示的胸膜腔积液等形态异常,需结合PET代谢信息判断是否为肿瘤受累。
  • PET/MRI检出的骨骼病灶需与骨髓活检等临床检查结果关联解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: In 2015, the revised International Pediatric Non-Hodgkin Lymphoma Staging System was published. It mentions [18F]-FDG-PET/MRI as the latest method to perform whole-body imaging. However, supporting data are pending. Our aim was to investigate the performance of whole-body [18F]-FDG-PET/MRI in pediatric non-Hodgkin lymphoma patients by using a limited number of MRI sequences. MATERIALS AND METHODS: Ten pediatric patients with histologically proven non-Hodgkin lymphoma underwent whole-body [18F]-FDG-PET/MRI at staging. The retrospective analysis included three steps: First, [18F]-FDG-PET and MR scans were evaluated separately by a nuclear medicine physician and a pediatric radiologist. Nineteen nodal and two extranodal regions as well as six organs were checked for involvement. Second, discrepant findings were reviewed together in order to reach consensus. Third, [18F]-FDG-PET/MRI findings were correlated with the results of other clinical investigations. RESULTS: Of the 190 lymph node regions evaluated, four were rated controversial. Consensus was reached by considering metabolic, functional and morphologic information combined. Concordantly, [18F]-FDG-PET and MRI detected Waldeyer's ring involvement in two patients whose Waldeyer's ring was negative on clinical assessment. In four patients MRI showed pleural effusion. However, in only two of them an increased glucose metabolism as a reliable sign of pleural involvement was detectable. In six patients [18F]-FDG-PET and MRI detected skeletal lesions although bone marrow biopsy was positive in only one of them. CONCLUSION: Despite the small number of cases evaluated, whole-body [18F]-FDG-PET turned out to be a valuable tool for staging of pediatric non-Hodgkin lymphoma.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Kurch L, Kluge R, Sabri O, et al. Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation. EJNMMI Res. 2021. PMID: 34216300. doi:10.1186/s13550-021-00804-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。